Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Envisions Updating 510(k) Paradigm To Capture Standards Adherence

This article was originally published in The Gray Sheet

Executive Summary

FDA's Office of Device Evaluation will update its data management systems to ensure that premarket notification submissions carrying a promissory statement of adherence to standards can be considered as abbreviated 510(k)s.

You may also be interested in...



FDA Enlists CEO Support To Invigorate Slumping Abbreviated 510(k) Program

CEO endorsement is essential to stimulate growth of FDA's abbreviated 510(k) program, staffers and industry representatives maintained at an AdvaMed standards conference in Rockville, Maryland Jan. 9-10.

FDA Enlists CEO Support To Invigorate Slumping Abbreviated 510(k) Program

CEO endorsement is essential to stimulate growth of FDA's abbreviated 510(k) program, staffers and industry representatives maintained at an AdvaMed standards conference in Rockville, Maryland Jan. 9-10.

Special 510(k) Submissions Rise 47% in Fiscal Year 2000

Industry submitted 583 "special 510(k)s" to FDA's Center for Devices and Radiological Health in FY 2000, an increase of 47% over the 396 applications submitted in FY 1999, according to CDRH officials.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT014352

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel